Inulicin

CAS No. 33627-41-7

Inulicin ( 1-O-Acetylbritannilactone )

Catalog No. M24280 CAS No. 33627-41-7

Inulicin, an active compound isolated from Inula Britannica L, inhibits VEGF-mediated activation of Src and FAK.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 147 In Stock
10MG 225 In Stock
25MG 376 In Stock
50MG 561 In Stock
100MG 798 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Inulicin
  • Note
    Research use only, not for human use.
  • Brief Description
    Inulicin, an active compound isolated from Inula Britannica L, inhibits VEGF-mediated activation of Src and FAK.
  • Description
    Inulicin, an active compound isolated from Inula Britannica L, inhibits VEGF-mediated activation of Src and FAK.
  • Synonyms
    1-O-Acetylbritannilactone
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX-2;FAK;NF-κB;Src
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    33627-41-7
  • Formula Weight
    308.4
  • Molecular Formula
    C17H24O5
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol:45 mg/mL (145.93 mM; Need ultrasonic)
  • SMILES
    O[C@H]1[C@@](C2=C)([H])[C@@](OC2=O)([H])CC(C)=C1[C@@H](C)CCCOC(C)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhengfu H, et al. 1-o-acetylbritannilactone (ABL) inhibits angiogenesis and lung cancer cell growth through regulating VEGF-Src-FAK signaling. Biochem Biophys Res Commun. 2015 Aug 21;464(2):422-7.
molnova catalog
related products
  • SC 58125

    SC-58125 is a selective cyclooxygenase 2 (COX-2) inhibitor,?with an IC50 of 0.04 μM. SC-58125 exhibits antitumor activity in vitro and in vivo, and it also can inhibit edema at the inflammatory site and is analgesicSC-58125 treatment on the growth of human colon carcinoma cells in nude mice.?

  • PTUPB

    PTUPB is a novel dual acting COX-2/sEH inhibitor with IC50 of 1.26 uM/0.9 nM.

  • Lornoxicam

    Lornoxicam (chlortenoxicam) is a new nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic, anti-inflammatory and antipyretic properties.